Browse diseases

… AM, Elliott PM, Baboonian C, Davison F, Davies MJ, McKenna WJ. Hypertrophic cardiomyopathy. Circulation 2001;104(12):1380–4.Olivotto I, Cecchi F, Casey SA…

… arrhythmia in patients with ischaemic heart disease. New-onset atrial fibrillation after coronary revascularisation is associated with adverse car…

…on for persistent atrial fibrillation, 185 (37%) for paroxysmal atrial fibrillation and 3 (1%) were unknown. 244 (49%) of cases used Cryoballoon ab…

…n this patient cohort, anticoagulation therapy in patients with atrial fibrillation is associated with a substantial burden of perioperative challe…

…e KN, et al. The role of left atrial volume index in predicting atrial fibrillation recurrence after catheter ablation. Journal of the American Col…

…er the receiver operating characteristic curve. Performance for atrial fibrillation was more variable.Conclusion Incorporating clinician eye-tracki…

…rom baseline to 18 weeks in quality of life, assessed using the Atrial Fibrillation Effect on QualiTy-of-life questionnaire. VIR-SAAF is the first …

…Background Atrial fibrillation (AF) is the most prevalent cardiac arrhythmia globally, affecti…

…rial fibrillation (7/8, 87.5%; p<0.001). Notably, four of seven atrial fibrillation–related cases (57.1%) were not on appropriate anticoagulation a…

…were taking an antihypertensive. More than 75% of patients with ischaemic heart disease were taking an antithrombotic or a lipid-lowering agent and mor…

…er-quantified PVCs. Meta-regression identified a 5.4% increased atrial fibrillation risk per 1% increment in PVC burden.Conclusion Frequent PVCs co…

…Background Diabetes mellitus (DM) is a common comorbidity in hypertrophic cardiomyopathy (HCM) and may exacerbate arrhythmic risk, promote structural re…